Characterization of uptake of 2-deoxy-2-[18F] fluoro-D-glucose by fungal-associated inflammation: The standardized uptake value is greater for lesions of blastomycosis than for lymphoma in dogs with naturally occurring disease

Molecular Imaging and Biology

Volumn 4, Issue 3, 2002, Pages 201-207

  Bassett, Cary L M ^a,c   Daniel, Gregory B ^a   Legendre, Alfred M ^a   Bochsler, Philip N ^a   Smith, Gary T ^b  

^a UNIVERSITY OF TENNESSEE   (United States)

^b UNIVERSITY OF TENNESSEE MEDICAL CENTER   (United States)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Blastomyces; Blastomycosis; Dog; FDG; SUV

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLASTOMYCOSIS; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DOG; DRUG UPTAKE; INFLAMMATION; ISOTOPE LABELING; LYMPHOMA; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; REFERENCE VALUE; STANDARDIZATION; WHOLE BODY SCINTISCANNING;

BLASTOMYCES; CANIS FAMILIARIS;

EID: 0036299632     PISSN: 15361632     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1536-1632(02)00002-1     Document Type: Article

References (30)

1. Evaluation of the solitary pulmonary nodule by positron emission tomography imaging
2. Likelihood of malignancy in a solitary pulmonary nodule: Comparison of Bayesian analysis and results of FDG-PET scan
3. Solitary pulmonary nodules: Detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose
4. Probability of malignancy in solitary pulmonary nodules using fluorine-18-FDG and PET
5. Characterization of chest masses by FDG positron emission tomography
6. Differentiating benign from malignant lung lesions using "quantitative" parameters of FDG PET images
7. Evaluation of pulmonary lesions with FDG-PET. Comparison of findings in patients with and without a history of prior malignancy
8. Semiquantitative and visual analysis of FDG-PET images in pulmonary abnormalities
9. Prospective investigation of positron emission tomography in lung nodules
10. Focal pulmonary abnormalities: Evaluation with F-18 fluorodeoxyglucose PET scanning
11. Positron emission tomography of lung tumors and mediastinal lymph nodes using [18F]fluorodeoxyglucose. The members of the PET-lung tumor study group
12. Fluorine-18 deoxyglucose and false-positive results: A major problem in the diagnostics of oncological patients
13. Normal physiological and benign pathological variants of 18-fluoro-2-deoxy-glucose positron-emission tomography scanning: Potential for error in interpretation
14. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: High accumulation in macrophages and granulation tissues studied by microautoradiography
15. Cancer or inflammation? A holy grail for nuclear medicine
16. Pitfalls in oncologic diagnosis with FDG PET imaging: Physiologic and benign variants
17. High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue
18. Stimulation of glycolysis as an activation signal in rat peritoneal macrophages
19. FDG-PET in infectious lesions: The detection and assessment of lesion activity
20. 125I-HSA
21. PET imaging in oncology
22. Applications of PET in oncologic imaging
23. Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management
24. Pulmonary abnormalities and PET data analysis: A retrospective study
25. Blastomycosis
26. Blastomycosis
27. Blastomycosis
28. Canine lymphomas and lymphoid leukemias
29. Lymphoma